NPORT-EX 2 464743VYSmCapOppsFd.htm

 

Voya SmallCap Opportunities Fund PORTFOLIO OF INVESTMENTS
as of August 31, 2020 (Unaudited)

 
Shares     Value Percentage
of Net
Assets
COMMON STOCK: 99.9%
    Communication Services: 1.0%
59,597 (1) QuinStreet, Inc. $         783,701   0.3
139,609 (1) Vonage Holdings Corp. 1,598,523   0.7
      2,382,224   1.0
         
    Consumer Discretionary: 16.4%
32,641   Aarons, Inc. 1,824,306   0.7
13,764 (1) Bright Horizons Family Solutions, Inc. 1,830,750   0.8
59,420 (1) Caesars Entertainment, Inc. 2,721,436   1.1
14,769 (1) Chegg, Inc. 1,089,066   0.5
39,420 (1) CROCS, Inc. 1,573,252   0.6
12,932 (1) Deckers Outdoor Corp. 2,636,447   1.1
42,333 (1),(2) GrowGeneration Corp. 675,423   0.3
11,067 (1) Helen of Troy Ltd. 2,288,877   0.9
20,737   LCI Industries 2,356,345   1.0
18,318   Marriott Vacations Worldwide Corp. 1,734,165   0.7
14,206 (1) Murphy USA, Inc. 1,915,821   0.8
67,311 (1) National Vision Holdings, Inc. 2,528,874   1.0
19,686 (1) Ollie's Bargain Outlet Holdings, Inc. 1,880,800   0.8
23,514 (1) Planet Fitness, Inc. 1,429,416   0.6
6,156 (1) RH 2,034,866   0.8
20,123   Strategic Education, Inc. 2,064,016   0.8
48,186   Texas Roadhouse, Inc. 3,035,236   1.2
14,689 (1) TopBuild Corp. 2,259,168   0.9
15,597   Wingstop, Inc. 2,548,550   1.0
38,465   Winnebago Industries 2,076,341   0.8
      40,503,155   16.4
         
    Consumer Staples: 2.4%
44,474 (1) Grocery Outlet Holding Corp. 1,829,216   0.7
62,560 (1) Performance Food Group Co. 2,284,065   0.9
136,087   Primo Water Corp. 1,861,670   0.8
      5,974,951   2.4
         
    Financials: 3.6%
23,224   LPL Financial Holdings, Inc. 1,908,084   0.8
9,152   Morningstar, Inc. 1,465,693   0.6
35,789   Prosperity Bancshares, Inc. 1,951,216   0.8
86,596 (1),(2) Selectquote, Inc. 1,580,377   0.6
14,414   Signature Bank 1,398,590   0.5
55,263 (1),(2) Spartan Energy Acquisition Corp. 718,419   0.3
      9,022,379   3.6
         
    Health Care: 27.9%
50,946 (1) 1Life Healthcare, Inc. 1,486,095   0.6
77,734 (1),(2) Aerie Pharmaceuticals, Inc. 855,074   0.4
35,989 (1),(2) Akouos, Inc. 806,873   0.3
5,096 (1) Amedisys, Inc. 1,232,722   0.5
122,037 (1) Amicus Therapeutics, Inc. 1,781,740   0.7
42,634 (1),(2) Applied Therapeutics, Inc. 1,027,479   0.4
168,277 (1) Ardelyx, Inc. 965,910   0.4
15,369 (1) Arena Pharmaceuticals, Inc. 1,073,064   0.4
43,533 (1) Arrowhead Pharmaceuticals, Inc. 1,838,834   0.7
30,064 (1),(2) Axonics Modulation Technologies, Inc. 1,270,505   0.5
28,796 (1) Biohaven Pharmaceutical Holding Co. Ltd. 1,825,378   0.7
75,024 (1) BioLife Solutions, Inc. 1,599,512   0.7
26,985 (1) Blueprint Medicines Corp. 2,089,449   0.9
17,505 (1),(2) CryoPort, Inc. 971,177   0.4
113,391 (1) Cymabay Therapeutics, Inc. 733,640   0.3
65,361 (1) Dicerna Pharmaceuticals, Inc. 1,210,486   0.5
31,834   Encompass Health Corp. 2,076,850   0.8
103,342 (1) Epizyme, Inc. 1,343,446   0.5
37,518 (1) FibroGen, Inc. 1,681,932   0.7
65,235 (1) G1 Therapeutics, Inc. 1,001,357   0.4
123,798 (1) GenMark Diagnostics, Inc. 1,605,660   0.7
32,383 (1) Globus Medical, Inc. 1,830,287   0.7
22,146 (1) Haemonetics Corp. 1,985,610   0.8
54,142 (1) HealthEquity, Inc. 3,112,082   1.3
20,918   Hill-Rom Holdings, Inc. 1,961,899   0.8
72,677 (1) HMS Holdings Corp. 2,026,962   0.8
53,978 (1) Homology Medicines, Inc. 573,786   0.2
10,102 (1) Horizon Therapeutics Plc 758,862   0.3
57,616 (1) Insmed, Inc. 1,624,195   0.7
38,157 (1) Iovance Biotherapeutics, Inc. 1,271,773   0.5
29,829 (1) Krystal Biotech, Inc. 1,426,125   0.6
26,184 (1) Magellan Health, Inc. 1,975,845   0.8
22,042 (1) MyoKardia, Inc. 2,412,276   1.0
76,155 (1) NextCure, Inc. 684,633   0.3
24,003 (1) Novocure Ltd. 1,986,248   0.8
42,125 (1) Omnicell, Inc. 2,808,895   1.1
163,237 (1) OraSure Technologies, Inc. 1,913,138   0.8
36,902 (1),(2) Poseida Therapeutics, Inc. 346,510   0.1
34,101 (1) PTC Therapeutics, Inc. 1,685,442   0.7
34,539 (1) RAPT Therapeutics, Inc. 918,737   0.4
10,607 (1) Reata Pharmaceuticals, Inc. 1,113,205   0.5
54,801 (1) Rocket Pharmaceuticals, Inc. 1,401,262   0.6
36,538 (1),(2) Stoke Therapeutics, Inc. 1,073,121   0.4
35,176 (1) Syneos Health, Inc. 2,219,606   0.9
40,996 (1),(2) Tabula Rasa HealthCare, Inc. 2,074,398   0.8
51,526 (1),(2) UroGen Pharma Ltd. 1,292,787   0.5
      68,954,867   27.9
         
    Industrials: 18.9%
24,306 (1) ASGN, Inc. 1,744,442   0.7
42,986 (1) AZEK Co., Inc./The 1,697,087   0.7
39,303   Brink's Co. 1,900,693   0.8

 

 

Voya SmallCap Opportunities Fund PORTFOLIO OF INVESTMENTS
as of August 31, 2020 (Unaudited) (Continued)

 
Shares     Value Percentage
of Net
Assets
COMMON STOCK: (continued)
    Industrials: (continued)
113,055 (1) Builders FirstSource, Inc. $         3,461,744   1.4
38,692   Crane Co. 2,187,646   0.9
24,340   EMCOR Group, Inc. 1,825,743   0.8
14,915 (1) FTI Consulting, Inc. 1,711,645   0.7
10,655 (1) Generac Holdings, Inc. 2,024,237   0.8
38,716 (1) IAA, Inc. 2,025,621   0.8
27,800   John Bean Technologies Corp. 2,849,778   1.2
10,184   Lindsay Corp. 1,017,687   0.4
18,363   Regal Beloit Corp. 1,815,366   0.7
28,345   Simpson Manufacturing Co., Inc. 2,787,447   1.1
30,141 (1) SiteOne Landscape Supply, Inc. 3,769,132   1.5
50,800   Skywest, Inc. 1,709,420   0.7
29,624   Tetra Tech, Inc. 2,734,592   1.1
33,014   UFP Industries, Inc. 1,959,381   0.8
23,051 (1) Vicor Corp. 2,006,129   0.8
24,514   Watts Water Technologies, Inc. 2,347,216   1.0
66,205   Werner Enterprises, Inc. 3,046,092   1.2
23,387   Woodward, Inc. 2,004,032   0.8
      46,625,130   18.9
         
    Information Technology: 24.8%
58,079 (1) ACI Worldwide, Inc. 1,706,361   0.7
35,177 (1) Advanced Energy Industries, Inc. 2,607,319   1.1
37,453 (1) Blackline, Inc. 3,272,269   1.3
8,952 (1) CACI International, Inc. 2,096,469   0.8
74,948 (1) Calix, Inc. 1,457,739   0.6
37,197 (1) Envestnet, Inc. 3,086,979   1.2
12,885 (1) Everbridge, Inc. 1,914,840   0.8
60,948   EVERTEC, Inc. 2,134,399   0.9
7,857 (1) Five9, Inc. 1,001,296   0.4
17,073 (1) Inphi Corp. 1,945,980   0.8
46,507 (1) j2 Global, Inc. 3,255,025   1.3
104,193 (1) Lattice Semiconductor Corp. 2,979,920   1.2
25,700 (1) LivePerson, Inc. 1,533,262   0.6
49,084 (1) LiveRamp Holdings, Inc. 2,740,851   1.1
20,228 (1) Lumentum Holdings, Inc. 1,739,608   0.7
63,193 (1) Mimecast Ltd. 3,111,623   1.3
59,349 (1) Onto Innovation, Inc. 1,854,063   0.8
19,136 (1) Proofpoint, Inc. 2,098,645   0.8
27,720 (1) Q2 Holdings, Inc. 2,696,879   1.1
22,288 (1) Qualys, Inc. 2,365,648   1.0
35,557 (1) RealPage, Inc. 2,226,579   0.9
95,616 (1) Repay Holdings Corp. 2,419,085   1.0
23,227 (1) Silicon Laboratories, Inc. 2,378,677   1.0
58,775 (1) Sprout Social, Inc. 2,277,531   0.9
50,995 (1) Super Micro Computer, Inc. 1,396,753   0.6
103,920 (1) Verra Mobility Corp. 1,097,915   0.4
42,576 (1) Vertex, Inc. 1,090,371   0.4
207,451 (1) Viavi Solutions, Inc. 2,766,359   1.1
      61,252,445   24.8
         
    Materials: 2.6%
50,657   Avient Corp. 1,292,767   0.5
27,990   Compass Minerals International, Inc. 1,593,471   0.6
29,018   Minerals Technologies, Inc. 1,472,663   0.6
40,063   Sensient Technologies Corp. 2,212,279   0.9
      6,571,180   2.6
         
    Real Estate: 2.3%
20,651   EastGroup Properties, Inc. 2,749,887   1.1
32,901   QTS Realty Trust, Inc. 2,231,346   0.9
20,248   RE/MAX Holdings, Inc. 711,515   0.3
      5,692,748   2.3
         
  Total Common Stock    
  (Cost $224,963,353) 246,979,079   99.9
       
       
Principal
Amount†
    Value Percentage
of Net
Assets
SHORT-TERM INVESTMENTS: 5.3%
    Repurchase Agreements: 3.7%
1,250,865 (3) Cantor Fitzgerald Securities, Repurchase Agreement dated 08/31/20, 0.10%, due 09/01/20 (Repurchase Amount $1,250,868, collateralized by various U.S. Government/U.S. Government Agency Obligations, 0.415%-9.000%, Market Value plus accrued interest $1,275,882, due 10/01/20-07/20/70) 1,250,865   0.5
1,804,749 (3) Citadel Securities LLC, Repurchase Agreement dated 08/31/20, 0.14%, due 09/01/20 (Repurchase Amount $1,804,756, collateralized by various U.S. Government Securities, 0.000%-8.000%, Market Value plus accrued interest $1,840,851, due 09/03/20-05/15/50) 1,804,749   0.7
2,123,012 (3) Citigroup, Inc., Repurchase Agreement dated 08/31/20, 0.09%, due 09/01/20 (Repurchase Amount $2,123,017, collateralized by various U.S. Government/U.S. Government Agency Obligations, 1.125%-5.500%, Market Value plus accrued interest $2,165,472, due 03/31/24-07/20/70) 2,123,012   0.9

 

 

Voya SmallCap Opportunities Fund PORTFOLIO OF INVESTMENTS
as of August 31, 2020 (Unaudited) (Continued)

 

Principal
Amount†
    Value Percentage
of Net
Assets
SHORT-TERM INVESTMENTS: (continued)
    Repurchase Agreements (continued)
  2,123,012 (3) MUFG Securities America Inc., Repurchase Agreement dated 08/31/20, 0.09%, due 09/01/20 (Repurchase Amount $2,123,017, collateralized by various U.S. Government Agency Obligations, 2.000%-4.500%, Market Value plus accrued interest $2,165,472, due 01/01/30-08/01/50) $        2,123,012   0.9
  1,819,701 (3) RBC Dominion Securities Inc., Repurchase Agreement dated 08/31/20, 0.09%, due 09/01/20 (Repurchase Amount $1,819,705, collateralized by various U.S. Government/U.S. Government Agency Obligations, 0.000%-6.000%, Market Value plus accrued interest $1,856,095, due 09/01/20-07/01/50) 1,819,701   0.7
       
  Total Repurchase Agreements    
  (Cost $9,121,339) 9,121,339   3.7
       
Shares     Value Percentage
of Net
Assets
    Mutual Funds: 1.6%
3,850,000 (4) Goldman Sachs Financial Square Government Fund - Institutional Shares, 0.020%    
    (Cost $3,850,000) 3,850,000  1.6
         
  Total Short-Term Investments    
  (Cost $12,971,339) 12,971,339 5.3
       
  Total Investments in Securities
(Cost $237,934,692)
$ 259,950,418 105.2
  Liabilities in Excess of Other Assets (12,889,771)   (5.2)
  Net Assets $ 247,060,647   100.0

 

† Unless otherwise indicated, principal amount is shown in USD.
(1) Non-income producing security.
(2) Security, or a portion of the security, is on loan.
(3) All or a portion of the security represents securities purchased with cash collateral received for securities on loan.
(4) Rate shown is the 7-day yield as of August 31, 2020.

 

 

Voya SmallCap Opportunities Fund PORTFOLIO OF INVESTMENTS
as of August 31, 2020 (Unaudited) (Continued)

 

Fair Value Measurements
The following is a summary of the fair valuations according to the inputs used as of August 31, 2020 in valuing the assets and liabilities:
 
    Quoted Prices
in Active Markets
for Identical
Investments
(Level 1)
    Significant
Other
Observable
Inputs
(Level 2)
    Significant
Unobservable
Inputs
(Level 3)
    Fair Value
at
August 31, 2020
 
Asset Table                    
Investments, at fair value                    
Common Stock*  $246,979,079   $–   $–   $246,979,079 
Short-Term Investments   3,850,000    9,121,339    –    12,971,339 
Total Investments, at fair value  $250,829,079   $9,121,339   $–   $259,950,418 

 

* For further breakdown of Common Stock by sector, please refer to the Portfolio of Investments.

 

At August 31, 2020, the aggregate cost of securities and other investments and the composition of unrealized appreciation and depreciation of securities and other investments on a tax basis were:
 
  Cost for federal income tax purposes was $255,367,287.  
  Net unrealized appreciation consisted of:      
  Gross Unrealized Appreciation $ 32,462,029      
  Gross Unrealized Depreciation (27,878,898)      
  Net Unrealized Appreciation $ 4,583,131